Sort
78,016 grants matching “breast cancer”
Mayo Clinic Breast Cancer SPORE
$2,130,960James Newell Ingle · Mayo Clinic Rochester · P50 · FY2008 · CA
Nanomaterials for Cancer Diagnostics and Therapeutics
$2,130,727Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2013 · CA
Study of Osteoporotic Fractures
$2,130,348Steven R Cummings · California Pacific Med Ctr Res Institute · R01 · FY2010 · AG
Center for Systematic Modeling of Cancer Development
$2,129,742Stephen Tc Wong · Methodist Hospital Research Institute · U54 · FY2011 · CA
Studies of Populations Exposed to Occupational Sources of Radiation
$2,127,539Martha S Linet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Cobre for Signal Transduction and Cancer
$2,127,315Daniel Flynn · West Virginia University · P20 · FY2007 · RR
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$2,126,969Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2011 · GM
Community Clinical Oncology Program
$2,126,787Shaker R Dakhil · Via Christi Regional Medical Center · U10 · FY2013 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,125,238Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
$2,124,555Laura J Esserman · University Of California, San Francisco · P01 · FY2018 · CA
TARGETING FATTY ACID SYNTHASE: A MECHANISM-GUIDED APPROACH TO DEVELOP A NOVEL THERAPEUTIC INTERVENTION FOR DRUG-RESISTANT BREAST CANCER
$2,124,182Mayo Clinic · · FY2016 · Defense Health Agency
A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors
$2,122,410Ann H Partridge · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,122,084Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
$2,121,223Roberta Diaz Brinton · University Of Arizona · R01 · FY2022 · AG
Cancer Proteome Center at Washington Univ, Univ of North Carolina
$2,120,962Matthew J Ellis · Washington University · U24 · FY2013 · CA
Molecular Epidemiology of Nutrition and Cancer in the Multiethnic Cohort Study
$2,120,588Laurence N. Kolonel · University Of Hawaii At Manoa · P01 · FY2009 · CA
Selective Targeting of Pancreatic Cancer SPORE
$2,120,012Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
SPORE in Breast Cancer
$2,119,686Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2009 · CA
SPORE in Breast Cancer
$2,119,685Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2010 · CA
Surgery Branch Cell Prep Core
$2,119,096Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Cell Production Core Facility
$2,119,096Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
EPIDEMIOLOGIC AND GENETIC STUDIES OF BREAST CANCER
$2,119,031Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2003 · CA
Infections, immunity, and inflammation in cancer
$2,118,458Eric A Engels · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Center for Pre-Clinical Cancer Research
$2,118,025Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2024 · GM
SPORE in Breast Cancer
$2,116,400Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA